Literature DB >> 26051969

Distribution and Within-Family Specificity of Quantitative Autistic Traits in Patients with Neurofibromatosis Type I.

John N Constantino1, Yi Zhang2, Kieran Holzhauer3, Sayli Sant2, Kyna Long2, Alicia Vallorani4, Leena Malik2, David H Gutmann4.   

Abstract

OBJECTIVE: To examine the distribution of quantitative autistic traits (QATs) in an independent neurofibromatosis type I (NF1) sample, the relationships between QAT, sex, and attention deficit hyperactivity disorder (ADHD) symptomatology, and to explore evidence for QAT mutational specificity within families. STUDY
DESIGN: Age-appropriate versions of the Social Responsiveness Scale, second edition and the Conners Adult ADHD Rating Scales were completed for 103 patients with NF1 from the Washington University Neurofibromatosis Center.
RESULTS: Patients with NF1 exhibited a pathologically shifted unimodal distribution for QAT. Forty-four percent of the subjects exhibited a QAT burden at or above 1 SD from the population mean; 13% scored at or above the extreme first percentile of the general population distribution. Elevations in ADHD symptomatology exhibited a distinct bimodal distribution; however, mean ADHD index scores were equivalent in patients who had been diagnosed in the community with ADHD compared with those who had not. We observed striking within-family associations for QAT, reflected by an Social Responsiveness Scale, second edition intraclass correlation of 0.77 in pairings of first degree relatives with NF1.
CONCLUSIONS: Impairments in reciprocal social behavior and attention affect a large proportion of patients with NF1 throughout life and are often clinically unrecognized. Further exploration of genotype-phenotype correlation is strongly warranted for the purpose of gaining insights into mechanisms by which specific mutational variations in the NF1 gene may influence autistic trait severity.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26051969      PMCID: PMC4792262          DOI: 10.1016/j.jpeds.2015.04.075

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  29 in total

Review 1.  Clinical manifestations and management of neurofibromatosis type 1.

Authors:  James H Tonsgard
Journal:  Semin Pediatr Neurol       Date:  2006-03       Impact factor: 1.636

2.  Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

Authors:  Karin S Walsh; Jorge I Vélez; Peter G Kardel; Daniel M Imas; Maximilian Muenke; Roger J Packer; Francisco X Castellanos; Maria T Acosta
Journal:  Dev Med Child Neurol       Date:  2012-11-16       Impact factor: 5.449

3.  Neurofibromatosis type 1 gene mutation analysis using sequence capture and high-throughput sequencing.

Authors:  Elina Uusitalo; Anna Hammais; Elina Palonen; Annika Brandt; Ville-Veikko Mäkelä; Roope Kallionpää; Eeva-Mari Jouhilahti; Minna Pöyhönen; Juhani Soini; Juha Peltonen; Sirkku Peltonen
Journal:  Acta Derm Venereol       Date:  2014-11       Impact factor: 4.437

4.  Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder.

Authors:  Shelley L Hyman; E Arthur Shores; Kathryn N North
Journal:  Dev Med Child Neurol       Date:  2006-12       Impact factor: 5.449

5.  Neurofibromatosis type 1 and autism spectrum disorder.

Authors:  Shruti Garg; Jonathan Green; Kathy Leadbitter; Richard Emsley; Annukka Lehtonen; D Gareth Evans; Susan M Huson
Journal:  Pediatrics       Date:  2013-11-04       Impact factor: 7.124

6.  Rapid quantitative assessment of autistic social impairment by classroom teachers.

Authors:  John N Constantino; Patricia D Lavesser; Yi Zhang; Anna M Abbacchi; Teddi Gray; Richard D Todd
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-12       Impact factor: 8.829

7.  Autistic traits in the general population: a twin study.

Authors:  John N Constantino; Richard D Todd
Journal:  Arch Gen Psychiatry       Date:  2003-05

8.  Demographic and clinical correlates of autism symptom domains and autism spectrum diagnosis.

Authors:  Thomas W Frazier; Eric A Youngstrom; Rebecca Embacher; Antonio Y Hardan; John N Constantino; Paul Law; Robert L Findling; Charis Eng
Journal:  Autism       Date:  2013-10-08

9.  Parental social responsiveness and risk of autism spectrum disorder in offspring.

Authors:  Kristen Lyall; John N Constantino; Marc G Weisskopf; Andrea L Roberts; Alberto Ascherio; Susan L Santangelo
Journal:  JAMA Psychiatry       Date:  2014-08       Impact factor: 21.596

10.  The female protective effect in autism spectrum disorder is not mediated by a single genetic locus.

Authors:  Jake Gockley; A Jeremy Willsey; Shan Dong; Joseph D Dougherty; John N Constantino; Stephan J Sanders
Journal:  Mol Autism       Date:  2015-05-13       Impact factor: 7.509

View more
  13 in total

1.  RASopathies are associated with a distinct personality profile.

Authors:  Varoona Bizaoui; Jessica Gage; Rita Brar; Katherine A Rauen; Lauren A Weiss
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-04-16       Impact factor: 3.568

2.  Social Function and Autism Spectrum Disorder in Children and Adults with Neurofibromatosis Type 1: a Systematic Review and Meta-Analysis.

Authors:  Anita K Chisholm; Vicki A Anderson; Natalie A Pride; Stephanie Malarbi; Kathryn N North; Jonathan M Payne
Journal:  Neuropsychol Rev       Date:  2018-08-11       Impact factor: 7.444

3.  Multidimensional Influences on Autism Symptom Measures: Implications for Use in Etiological Research.

Authors:  Karoline Alexandra Havdahl; Vanessa Hus Bal; Marisela Huerta; Andrew Pickles; Anne-Siri Øyen; Camilla Stoltenberg; Catherine Lord; Somer L Bishop
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-09-28       Impact factor: 8.829

4.  Associations between parental broader autism phenotype and child autism spectrum disorder phenotype in the Study to Explore Early Development.

Authors:  Eric Rubenstein; Lisa D Wiggins; Laura A Schieve; Chyrise Bradley; Carolyn DiGuiseppi; Eric Moody; Juhi Pandey; Rebecca Edmondson Pretzel; Annie Green Howard; Andrew F Olshan; Brian W Pence; Julie Daniels
Journal:  Autism       Date:  2018-01-29

5.  Social competence in children and young people treated for a brain tumour.

Authors:  Alice Emond; Lesley Edwards; Samantha Peacock; Catherine Norman; Michael Evangeli
Journal:  Support Care Cancer       Date:  2016-06-16       Impact factor: 3.603

6.  Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT).

Authors:  Stephanie M Morris; Maria T Acosta; Shruti Garg; Jonathan Green; Susan Huson; Eric Legius; Kathryn N North; Jonathan M Payne; Ellen Plasschaert; Thomas W Frazier; Lauren A Weiss; Yi Zhang; David H Gutmann; John N Constantino
Journal:  JAMA Psychiatry       Date:  2016-12-01       Impact factor: 21.596

Review 7.  Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.

Authors:  Martha Milade Torres Nupan; Alberto Velez Van Meerbeke; Claudia Alejandra López Cabra; Paula Marcela Herrera Gomez
Journal:  Front Pediatr       Date:  2017-10-30       Impact factor: 3.418

Review 8.  Role of Genetics in the Etiology of Autistic Spectrum Disorder: Towards a Hierarchical Diagnostic Strategy.

Authors:  Cyrille Robert; Laurent Pasquier; David Cohen; Mélanie Fradin; Roberto Canitano; Léna Damaj; Sylvie Odent; Sylvie Tordjman
Journal:  Int J Mol Sci       Date:  2017-03-12       Impact factor: 5.923

9.  Autism Spectrum Disorder in an Unselected Cohort of Children with Neurofibromatosis Type 1 (NF1).

Authors:  S Eijk; S E Mous; G C Dieleman; B Dierckx; A B Rietman; P F A de Nijs; L W Ten Hoopen; R van Minkelen; Y Elgersma; C E Catsman-Berrevoets; R Oostenbrink; J S Legerstee
Journal:  J Autism Dev Disord       Date:  2018-07

10.  Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1.

Authors:  Jennifer A Janusz; Bonita P Klein-Tasman; Jonathan M Payne; Pamela L Wolters; Heather L Thompson; Staci Martin; Peter de Blank; Nicole Ullrich; Allison Del Castillo; Maureen Hussey; Kristina K Hardy; Kristina Haebich; Tena Rosser; Mary Anne Toledo-Tamula; Karin S Walsh
Journal:  Neurology       Date:  2021-07-06       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.